Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer (IRESSA&H&N)

This study is ongoing, but not recruiting participants.

Study NCT00681967. Last updated on May 20, 2008. Information provided by AstraZeneca

Please refer to this study by its ClinicalTrials.gov identifier: NCT00681967

Locations


Switzerland
	Research Site
	Basel, Switzerland
	Research Site
	Bern, Switzerland

Sponsors and Collaborators

AstraZeneca

Investigators


Principal Investigator:	Christoph Rochlitz, Prof Dr med	University Hospital of Basel

Study Director:	Madeleine Billeter, MD	AstraZeneca AG, Grafenau 10; 6300 Zug; Switzerland

Study Chair:	Verena Renggli	AstraZeneca AG, Grafenau 10; 6300 Zug; Switzerland